Physician profile
Mandar M Joshi
NPI 1730132242
$7,379.43
in general payments reported to CMS, 2019-2025
16 companies · $513 in 2025
The $513 reported for 2025 was more than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,404 · 2020: $225 · 2021: $324 · 2022: $437 · 2023: $1,779 · 2024: $698 · 2025: $513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,789 · Honoraria: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,789.20 |
| Honoraria | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardinal Health 108 LLC | $2,879.88 | 2019 | |
| Alimera Sciences, INC. | $2,446.09 | 2019-2024 | Iluvien, Yutiq |
| Regeneron Healthcare Solutions, INC. | $559.70 | 2019-2025 | Eylea, Eylea Hd |
| Abbvie INC. | $416.67 | 2022-2025 | |
| Genentech USA, INC. | $322.43 | 2020-2025 | Vabysmo, Susvimo |
| Astellas Pharma US INC | $217.45 | 2024-2025 | Izervay |
| Regeneron Pharmaceuticals, INC. | $127.65 | 2022 | |
| Apellis Pharmaceuticals, INC. | $100.56 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $91.59 | 2019-2020 | |
| Allergan, INC. | $68.89 | 2019-2021 | |
| Ani Pharmaceuticals, INC. | $33.12 | 2025 | Iluvien |
| Thea Pharma INC. | $30.56 | 2025 | Iyuzeh |
| Biogen, INC. | $26.66 | 2024 | Byooviz |
| Alcon Vision LLC | $24.07 | 2025 | Tryptyr |
| Bausch & Lomb Americas INC. | $19.14 | 2023 | Xipere |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vyera Pharmaceuticals, LLC | $14.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mandar Joshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.